Vodis Pharmaceuticals (VP) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock VP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period VP debate 'spin room' scene: Talking points and unscripted momentsOctober 22, 2024 | usatoday.comVice President Harris in ‘Excellent Health,’ Medical Report StatesOctober 14, 2024 | msn.comVance Confident, Walz Uneven in VP Debate Heavy on PolicyOctober 2, 2024 | wsj.comRead the full VP debate transcript from the Walz-Vance showdownOctober 2, 2024 | cbsnews.comAs Investigations Swirl, Another Adams Official ResignsSeptember 24, 2024 | nytimes.comTonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial OperationsSeptember 10, 2024 | markets.businessinsider.comKalVista Pharma Appoints Brian Piekos As New CFOSeptember 10, 2024 | markets.businessinsider.comThis Bipartisan Bill Would Upend America's Pharmaceutical IndustryAugust 20, 2024 | forbes.comHow they are reporting it: Kamala Harris' VP pick, Tim WalzAugust 9, 2024 | reuters.comKamala Harris campaign expected to announce VP running mate Tuesday morningAugust 7, 2024 | cbsnews.comVP Pick Walz’s Healthcare Policies Align With Harris’s RecordAugust 7, 2024 | forbes.comWhere Harris' VP Options Stand on HealthcareAugust 2, 2024 | msn.comHarris, Trump camps launch dueling ad blitzes to define VP for votersAugust 1, 2024 | foxnews.comBiden says he and Kamala Harris are ‘talking’ about VP pick, claims he ‘cured the economy’August 1, 2024 | nypost.comNPotential Harris VP pick ripped for ‘weird’ socialism comparison to 'neighborliness'August 1, 2024 | foxnews.comWho could Kamala Harris pick as her VP? Here are 10 potential running matesJuly 31, 2024 | cbsnews.comKamala Harris Is Vetting Two Women on Her VP ShortlistJuly 25, 2024 | yahoo.comUS drug industry middlemen defend business model amid accusations of raising patient costsJuly 24, 2024 | reuters.comPennsylvania Gov. Josh Shapiro among contenders for Kamala Harris VP pick. Here's whyJuly 23, 2024 | usatoday.comScorpius Holdings Appoints New VP of Business Development Shari Udoff-McDonaldMay 7, 2024 | tmcnet.comVP Harris announces more than $100 mln to support auto workersMay 6, 2024 | reuters.comCOVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™March 27, 2024 | tmcnet.comStates' drug pricing boards off to a slow startMarch 22, 2024 | msn.comVerrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference CallFebruary 25, 2024 | msn.comAbivax appoints Ana Sharma as Vice President, Global Head of QualityFebruary 7, 2024 | markets.businessinsider.comMedicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s HealthJanuary 24, 2024 | markets.businessinsider.comDr Reddy's becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023December 14, 2023 | msn.comBiden warns Big Pharma: Make your drugs cheaper or the US government will override your patentsDecember 7, 2023 | msn.comThe White House is threatening the patents of high-priced drugs developed with taxpayer dollarsDecember 7, 2023 | abcnews.go.comAmneal Pharma in pact with Strides to launch generic VascepaDecember 1, 2023 | msn.comAnavex Life Sciences Appoints Senior VP of Regulatory AffairsNovember 6, 2023 | markets.businessinsider.comXpeng's vice president suspended amid corruption investigation in supply chain managementOctober 14, 2023 | foxnews.comLexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart DrugOctober 9, 2023 | marketwatch.comStrengthening of vertical integration: Exyte completes acquisition of pure media specialist IntegaOctober 4, 2023 | markets.businessinsider.comVice PresidentSeptember 19, 2023 | newsweek.comNRepublican voters want Donald Trump. And his vice president? How about more Trump?August 28, 2023 | usatoday.comTeva Pharmaceuticals to pay $225M fine to settle price-fixing chargesAugust 22, 2023 | news.yahoo.comVertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call TranscriptAugust 1, 2023 | msn.comWhat has Kamala Harris done as vice president?May 29, 2023 | news.yahoo.comVice President Kamala Harris: Latest NewsMarch 31, 2023 | nytimes.comIonis announces GSK has advanced bepirovirsen into Phase 3 developmentFebruary 1, 2023 | yahoo.comZyVersa Therapeutics Reports Inducement Grant to Newly Appointed Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4)January 27, 2023 | yahoo.comThe way Medicare will negotiate down prescription drug prices takes shapeJanuary 12, 2023 | marketwatch.comGlenmark Pharmaceuticals launches congestive heart failure injection in United StatesJanuary 10, 2023 | msn.comMore families facing price shocks for lifesaving children's medicationsJanuary 7, 2023 | msn.comFDA to review preventative option for RSV in infants, developers sayJanuary 6, 2023 | cnn.comNew York doctors now required to prescribe naloxone to some patients on opioid painkillersJanuary 4, 2023 | msn.comVanda Pharma Says Phase II Study Of VQW-765 To Treat Anxiety Showed Lower Stress LevelsDecember 2, 2022 | markets.businessinsider.comVertex Pharmaceuticals (VRTX) Q3 2022 Earnings Call TranscriptOctober 27, 2022 | msn.comRVL Pharmaceuticals: Chapter 2 - A Developing QuandarySeptember 22, 2022 | seekingalpha.com Get Vodis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VP Media Mentions By Week VP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VP News Sentiment▼0.000.93▲Average Medical News Sentiment VP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VP Articles This Week▼01▲VP Articles Average Week Get the Latest News and Ratings for VP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Vodis Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ONC News FRX News TH News HBP News MDNA News COV News SVA News MBX News GSD News HEM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CNSX:VP) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vodis Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vodis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VP Stock Alerts